ANA Investigates Cannabis and Cannabinoids for MS Symptoms
07/20/2020
In this podcast, Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.
Michelle Cameron, MD, PT, MCR, is associate professor of neurology at the Oregon Health & Science University in Portland, Oregon.
Published in partnership with 
For more ANA investigates podcasts, visit our partners at the American Neurological Association.
